Application 216629
- Type
- ANDA
- Sponsor
- GRAVITI PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 20MG | No | No |
| 002 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 40MG | No | No |
| 003 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 80MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 64980-562 | Furosemide | Furosemide | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 64980-563 | Furosemide | Furosemide | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 64980-564 | Furosemide | Furosemide | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 69844-051 | furosemide | furosemide | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-052 | furosemide | furosemide | Graviti Pharmaceuticals Private Limited | ANDA | Current |
| 69844-053 | furosemide | furosemide | Graviti Pharmaceuticals Private Limited | ANDA | Current |